Entera Historical Cash Flow

ENTX Stock  USD 1.61  0.06  3.59%   
Analysis of Entera Bio cash flow over time is an excellent tool to project Entera Bio future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 10.5 M or Depreciation of 97.3 K as it is a great indicator of Entera Bio ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Entera Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Entera Bio is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

About Entera Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Entera balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Entera's non-liquid assets can be easily converted into cash.

Entera Bio Cash Flow Chart

At this time, Entera Bio's Stock Based Compensation is fairly stable compared to the past year. Depreciation is likely to rise to about 97.3 K in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 10.2 M in 2024.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Entera Bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Entera Bio operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Entera Bio's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Entera Bio current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.At this time, Entera Bio's Stock Based Compensation is fairly stable compared to the past year. Depreciation is likely to rise to about 97.3 K in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 10.2 M in 2024.

Entera Bio cash flow statement Correlations

0.840.03-0.350.66-0.710.170.720.52-0.28-0.540.70.12-0.710.790.15-0.64-0.37-0.2
0.840.23-0.40.64-0.550.330.510.7-0.14-0.560.80.14-0.660.770.26-0.47-0.06-0.09
0.030.230.050.20.330.96-0.51-0.060.01-0.350.030.750.030.390.070.20.330.82
-0.35-0.40.05-0.420.630.03-0.56-0.38-0.650.18-0.520.190.85-0.56-0.77-0.10.280.16
0.660.640.2-0.42-0.30.290.370.090.09-0.30.240.13-0.620.590.610.07-0.17-0.1
-0.71-0.550.330.63-0.30.28-0.94-0.590.060.25-0.710.110.87-0.7-0.190.60.450.26
0.170.330.960.030.290.28-0.460.09-0.08-0.350.080.79-0.010.40.030.130.280.73
0.720.51-0.51-0.560.37-0.94-0.460.44-0.02-0.270.65-0.35-0.80.590.26-0.59-0.59-0.5
0.520.7-0.06-0.380.09-0.590.090.44-0.23-0.140.70.09-0.480.41-0.11-0.510.05-0.13
-0.28-0.140.01-0.650.090.06-0.08-0.02-0.23-0.160.09-0.48-0.240.020.830.53-0.15-0.2
-0.54-0.56-0.350.18-0.30.25-0.35-0.27-0.14-0.16-0.730.070.32-0.66-0.270.530.470.1
0.70.80.03-0.520.24-0.710.080.650.70.09-0.73-0.17-0.660.740.23-0.68-0.34-0.26
0.120.140.750.190.130.110.79-0.350.09-0.480.07-0.170.00.31-0.330.040.320.89
-0.71-0.660.030.85-0.620.87-0.01-0.8-0.48-0.240.32-0.660.0-0.83-0.580.250.370.11
0.790.770.39-0.560.59-0.70.40.590.410.02-0.660.740.31-0.830.37-0.45-0.350.2
0.150.260.07-0.770.61-0.190.030.26-0.110.83-0.270.23-0.33-0.580.370.43-0.23-0.22
-0.64-0.470.2-0.10.070.60.13-0.59-0.510.530.53-0.680.040.25-0.450.430.450.25
-0.37-0.060.330.28-0.170.450.28-0.590.05-0.150.47-0.340.320.37-0.35-0.230.450.42
-0.2-0.090.820.16-0.10.260.73-0.5-0.13-0.20.1-0.260.890.110.2-0.220.250.42
Click cells to compare fundamentals

Entera Bio Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.